Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report

We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under‐recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab.

Detalles Bibliográficos
Autores principales: Yamamoto, Koichiro, Tokumasu, Kazuki, Oka, Kosuke, Hasegawa, Kou, Otsuka, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190675/
https://www.ncbi.nlm.nih.gov/pubmed/34136239
http://dx.doi.org/10.1002/ccr3.4305
_version_ 1783705733453316096
author Yamamoto, Koichiro
Tokumasu, Kazuki
Oka, Kosuke
Hasegawa, Kou
Otsuka, Fumio
author_facet Yamamoto, Koichiro
Tokumasu, Kazuki
Oka, Kosuke
Hasegawa, Kou
Otsuka, Fumio
author_sort Yamamoto, Koichiro
collection PubMed
description We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under‐recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab.
format Online
Article
Text
id pubmed-8190675
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81906752021-06-15 Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report Yamamoto, Koichiro Tokumasu, Kazuki Oka, Kosuke Hasegawa, Kou Otsuka, Fumio Clin Case Rep Clinical Images We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under‐recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab. John Wiley and Sons Inc. 2021-06-10 /pmc/articles/PMC8190675/ /pubmed/34136239 http://dx.doi.org/10.1002/ccr3.4305 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Images
Yamamoto, Koichiro
Tokumasu, Kazuki
Oka, Kosuke
Hasegawa, Kou
Otsuka, Fumio
Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report
title Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report
title_full Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report
title_fullStr Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report
title_full_unstemmed Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report
title_short Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report
title_sort isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: a case report
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190675/
https://www.ncbi.nlm.nih.gov/pubmed/34136239
http://dx.doi.org/10.1002/ccr3.4305
work_keys_str_mv AT yamamotokoichiro isolatedadrenocorticotropindeficiencyinducedbypembrolizumabforhypopharyngealcanceracasereport
AT tokumasukazuki isolatedadrenocorticotropindeficiencyinducedbypembrolizumabforhypopharyngealcanceracasereport
AT okakosuke isolatedadrenocorticotropindeficiencyinducedbypembrolizumabforhypopharyngealcanceracasereport
AT hasegawakou isolatedadrenocorticotropindeficiencyinducedbypembrolizumabforhypopharyngealcanceracasereport
AT otsukafumio isolatedadrenocorticotropindeficiencyinducedbypembrolizumabforhypopharyngealcanceracasereport

Ejemplares similares